Pleural effusion as a first sign of Ig D λ multiple myeloma;Épanchement pleural révélateur d'un myélome à Ig D λ

Annales de Medecine Interne

Volumn 154, Issue 1, 2003, Pages 70-72

  Maachi, Mustapha ^a   Fellahi, Soraya ^a   Diop, Marie Emilienne ^a   Francois, Thierry ^a   Capeau, Jacqueline ^a   Bastard, Jean Philippe ^a  

^a HÔPITAL TENON   (France)

Author keywords

Immunoglobulin D; Multiple myelome; Pleural effusion

Indexed keywords

IMMUNOGLOBULIN D; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; ALKYLATING AGENT; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN LAMBDA CHAIN;

AGED; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DYSPNEA; HUMAN; MULTIPLE MYELOMA; PLEURA EFFUSION; PROGNOSIS; SEPTIC SHOCK; COMPARATIVE STUDY; DRUG COMBINATION; IMMUNOELECTROPHORESIS; IMMUNOLOGY; MALE; TIME;

AGED; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; DRUG THERAPY, COMBINATION; DYSPNEA; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MELPHALAN; MULTIPLE MYELOMA; PLEURAL EFFUSION; PREDNISONE; TIME FACTORS;

EID: 0242584832     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. RODRIGUEZ JN, PEREIRA A, MARTINEZ JC, CONDE J, PUJOL E: Pleural effusion in multiple myeloma. Chest 1994; 105: 622-4.
2. KINTZER JS, ROSENNOW EC, KYLE RA: Thoracic and pulmonary abnormalities in multiple myeloma. Arch Intern Med 1978; 138: 727-30.
3. SASSER RL, YAM LT, LI CY: Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review. Acta Cytol 1990; 34: 479-85.
4. ELLOUMI M, FRIKHA M, MASMOUDI H, MSEDDI S, BEN AYED M, BOUAZIZ M, et al.: Plasmocytic pleural effusion disclosing multiple myeloma. Rev Mal Respir 2000; 17: 495-7.
5. LIN TL, SHIH LY, DUNN P, WANG PN, WU JH, KAO MC: Immunoglobulin D multiple myeloma. Changgeng Yi Xue Za Zhi 2000; 23: 451-7.
6. KAMAL MK, WILLIAMS E, POSKITT TR: IgD myeloma with malignant pleural effusion. South Med J 1987; 80: 657-8.
7. BLADE J, LUST JA, KYLE RA. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994; 12: 2398-404.
8. HJORTH M, HOLMBERG E, RODJER S, TURESSON I, WESTIN J, WISLOFF F: Survival in conventionally treated younger (< 60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG). Eur J Haematol 1999; 62: 271-7.
9. IANNITTO E, SCAGLIONE R, MUSSO M, ABBADESSA V, LICATA G: Intrapleural adriamycin in treatment of myelomatous pleural effusion: a case report. Haematologica 1988; 73: 325-6.
10. MAKINO S, YAMAHARA S, NAGAKE Y, KAMURA J: Bence-Jones myeloma with pleural effusion: response to alpha-interferon and combined chemotherapy. Intern Med 1992; 31: 617-21.
11. MOREAU P, FACON T, ATTAL M, HULIN C, et al.: Comparison of 200mg/m (2) melphalan and 8 Gy total body irradiation plus 140mg/m (2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial. Blood 2002; 99: 731-5.
12. MEOLI A, WILLSIE S, FIORELLA R: Myelomatous pleural effusion. South Med J 1997; 90: 65-8.